Gena Wang
Stock Analyst at Barclays
Total Price Targets
30
Stocks Covered
17
Sectors
Healthcare
Most Recent
Nov 24, 2025
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Gena Wang
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | $50.00 | $24.79 | +101.7% | 2 | Nov 24, 2025 |
| FDMT | 4D Molecular Therapeutics, Inc. | $33.00 | $9.17 | +259.9% | 2 | Nov 11, 2025 |
| PTCT | PTC Therapeutics, Inc. | $68.00 | $65.06 | +4.5% | 1 | Nov 5, 2025 |
| VRTX | Vertex Pharmaceuticals Incorporated | $414.00 | $425.06 | -2.6% | 2 | Nov 4, 2025 |
| NTLA | Intellia Therapeutics, Inc. | $24.00 | $13.20 | +81.8% | 2 | Oct 28, 2025 |
| CYTK | Cytokinetics, Incorporated | $82.00 | $64.40 | +27.3% | 3 | Oct 6, 2025 |
| KOD | Kodiak Sciences Inc. | $17.00 | $44.09 | -61.4% | 1 | Sep 25, 2025 |
| IONS | Ionis Pharmaceuticals, Inc. | $82.00 | $75.86 | +8.1% | 3 | Sep 23, 2025 |
| SRPT | Sarepta Therapeutics, Inc. | $18.00 | $21.60 | -16.7% | 3 | Jul 22, 2025 |
| EDIT | Editas Medicine, Inc. | $5.00 | $2.91 | +71.8% | 1 | Nov 5, 2024 |
| BMRN | BioMarin Pharmaceutical Inc. | $86.00 | $54.20 | +58.7% | 2 | Oct 4, 2024 |
| BCRX | BioCryst Pharmaceuticals, Inc. | $7.00 | $9.23 | -24.2% | 2 | Aug 6, 2024 |
| VIR | Vir Biotechnology, Inc. | $28.00 | $10.02 | +179.6% | 2 | Aug 2, 2024 |
| SLDB | Solid Biosciences Inc. | $18.00 | $7.14 | +151.9% | 1 | May 16, 2024 |
| ARCT | Arcturus Therapeutics Holdings Inc. | $25.00 | $8.64 | +189.2% | 1 | Nov 2, 2022 |
| MRNA | Moderna, Inc. | $210.00 | $44.65 | +370.3% | 1 | Feb 24, 2022 |
| ALNY | Alnylam Pharmaceuticals, Inc. | $210.00 | $297.62 | -29.4% | 1 | Oct 28, 2021 |
Recent Activity
- Nov 24, 2025— Set$50.00price target onRARE(Ultragenyx Pharmaceutical Inc.)
- Nov 11, 2025— Set$33.00price target onFDMT(4D Molecular Therapeutics, Inc.)
- Nov 5, 2025— Set$68.00price target onPTCT(PTC Therapeutics, Inc.)
- Nov 4, 2025— Set$414.00price target onVRTX(Vertex Pharmaceuticals Incorporated)
- Oct 28, 2025— Set$24.00price target onNTLA(Intellia Therapeutics, Inc.)
- Oct 6, 2025— Set$82.00price target onCYTK(Cytokinetics, Incorporated)
- Sep 25, 2025— Set$17.00price target onKOD(Kodiak Sciences Inc.)
- Sep 23, 2025— Set$82.00price target onIONS(Ionis Pharmaceuticals, Inc.)
- Sep 3, 2025— Set$71.00price target onCYTK(Cytokinetics, Incorporated)
- Sep 2, 2025— Set$78.00price target onIONS(Ionis Pharmaceuticals, Inc.)
- Jul 22, 2025— Set$18.00price target onSRPT(Sarepta Therapeutics, Inc.)
- Apr 24, 2025— Set$55.00price target onCYTK(Cytokinetics, Incorporated)
- Nov 5, 2024— Set$5.00price target onEDIT(Editas Medicine, Inc.)
- Oct 4, 2024— Set$86.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- Sep 16, 2024— Set$110.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- Aug 8, 2024— Set$203.00price target onSRPT(Sarepta Therapeutics, Inc.)
- Aug 6, 2024— Set$7.00price target onBCRX(BioCryst Pharmaceuticals, Inc.)
- Aug 2, 2024— Set$28.00price target onVIR(Vir Biotechnology, Inc.)
- Jun 13, 2024— Set$185.00price target onSRPT(Sarepta Therapeutics, Inc.)
- May 21, 2024— Set$27.00price target onVIR(Vir Biotechnology, Inc.)
Frequently Asked Questions
Who is Gena Wang?
Gena Wang is a stock analyst at Barclays covering 17 stocks primarily in Healthcare. They have issued 30 price targets since Jun 11, 2021.
What stocks does Gena Wang cover?
Gena Wang currently covers 17 stocks, including CYTK, IONS, SRPT, RARE, FDMT.
What is Gena Wang's latest price target?
Gena Wang's most recent price target was $50.00 on RARE (Ultragenyx Pharmaceutical Inc.), set on Nov 24, 2025.
What is Gena Wang's highest price target?
Gena Wang's highest issued price target is $414.00 on VRTX, set on Nov 4, 2025.
More Analysts at Barclays
Coverage based on publicly published price targets. Not investment advice.